Navigation Links
Asmanex Twisthaler launched by Schering-Plough for treatment of asthma

Asmanex Twisthaler has been launched by Schering-Plough as therapy in the control and management of mild, moderate or severe persistent asthma in patients 12 years of age and older. It was launched in the United Kingdom in January and is expected to be launched in the other European Union(EU) markets, in the next few months. Asmanex Twisthaler, a dry powder inhaler, contains the orally// inhaled corticosteroid mometasone furoate, which was discovered and developed by Schering-Plough Research Institute. The product employs a state-of-the-art, inhalation-driven device that does not use a propellant, thus eliminating the need for hand-breath coordination.

Asmanex Twisthaler represents a major new treatment option in helping asthma patients manage their disease and is a valuable addition to the therapies available to physicians for treating asthma, which is a serious and life-threatening disease. Richard Jay Kogan, President and CEO of Schering-Plough said that Asmanex, which is the first asthma therapy in international markets, represents an important advance for Schering-Plough and will significantly strengthen its respiratory portfolio, which includes Nasonex, an inhaled nasal steroid for allergies, and Clarinex, the once-daily non-sedating antihistamine. The Chairman, Hans-Jorg Kummer, added that the product's proven efficacy, convenient once-daily dosing and easy-to-use device would help patients better adhere to their dosing regimen and assist in achieving control of their asthma symptoms.


'"/>




Page: 1

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. New initiative launched to fight malaria by repelling mosquitoes
3. Clarithromycin tablets to be launched in India soon
4. Guide for physicians launched to help them identify alcohol disorders
5. New X-ray machine launched by GE Healthcare
6. Historic trial for tuberculosis launched together by leading drug companies
7. New tetanus-diphtheria combination vaccine launched by Serum Institute of India
8. Hot Air Balloon Festival launched in Rajasthan
9. Thyroid hormone treatment hastens recovery after cardiac surgery
10. Feeding channel created by malaria parasite - a new target for malaria treatments
11. Now umbilical cord helps in stroke treatment.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology: